Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
Clinical and Molecular Hepatology · 01.04.2023 · 29 (2) · 252-262
DOI: 10.3350/cmh.2023.0099 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.04.2023. Verfasst von Yuri Cho und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B, Chronic. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is highly prevalent and the third most common cause of cancer-related death in Asia. In contrast to the West, the main etiology of HCC in many Asian countries except Japan is chronic hepatitis B virus infection. Differences in the major causes of HCC lead to significant clinical and treatment differences. This review summarizes and compares guidelines on managing HCC from China, Hong Kong, Taiwan, Japan, and South Korea. From oncology and socio-economic perspectives, factors such as underlying diseases, staging methods, government policies, insurance coverage, and medical resources contribute to varying treatment strategies among countries. Furthermore, the differences in each guideline are fundamentally caused by the lack of incontrovertible medical evidence, and even existing results of clinical trials can be interpreted differently. This review will provide a complete overview of the current Asian guidelines for HCC in recommendations and in practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea.
Zitieren
APA
Cho, Y., Kim, B. H., & Park, J. W. (2023). Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison. Clinical and Molecular Hepatology, 29(2), 252-262. https://doi.org/10.3350/cmh.2023.0099
Vancouver
Cho Y, Kim BH, Park JW. Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison. Clinical and Molecular Hepatology. 2023;29(2):252-262. doi:10.3350/cmh.2023.0099
BibTeX
@article{Cho2023,
author = {Cho, Yuri and Kim, Bo Hyun and Park, Joong-Won},
title = {Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison},
journal = {Clinical and Molecular Hepatology},
year = {2023},
volume = {29},
number = {2},
pages = {252--262},
doi = {10.3350/cmh.2023.0099}
}
EUVIMED